Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.56 +0.17 (+0.96%)
Streaming Delayed Price Updated: 10:35 AM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
28 29 Next >
News headline image
3 Dividend Stocks to Double Up on Right Now ↗
While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio. 
Via The Motley Fool
News headline image
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy. ↗
Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock. 
Via The Motley Fool
News headline image
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months ↗
An activist investor is taking a stake in Kenvue stock. 
Via The Motley Fool
News headline image
Is Kenvue Stock a Buy Now? ↗
The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved. 
Via The Motley Fool
News headline image
10 Analysts Have This To Say About Kenvue ↗
 
Via Benzinga
News headline image
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises ↗
The activist investor says Pfizer has underperformed its peers and the broader market since 2019. 
Via Investor's Business Daily
News headline image
Navigating 10 Analyst Ratings For Kenvue ↗
 
Via Benzinga
News headline image
P/E Ratio Insights for Kenvue ↗
 
Via Benzinga
News headline image
There are signs that NYSE:KVUE may be ready to breakout. ↗
KENVUE INC is setting up nicely for a breakout. 
Via Chartmill
News headline image
Nvidia Among Five Best S&P 500 Stocks Today ↗
Pfizer spinoff Kenvue led the S&P 500 on Monday. Nvidia was close behind. 
Via Investor's Business Daily
Topics Stocks
News headline image
Dow Drops 320 Points as Stocks Cool Off ↗
Stocks are stumbling out of the gate this week. 
Via Talk Markets
Topics Stocks
News headline image
What's Going On With Kenvue Stock Monday? ↗
Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has acquired a stake in the company. 
Via Benzinga
News headline image
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday? ↗
U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the... 
Via Benzinga
News headline image
Analyst Ratings For Kenvue ↗
 
Via Benzinga
News headline image
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies ↗
Elf Beauty appeared to rally along with KVUE on Monday. 
Via Investor's Business Daily
Topics Stocks
News headline image
Activist Investor Starboard Acquires Stake In Band-Aid Maker Kenvue, Shares Jump ↗
Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge. 
Via Talk Markets
News headline image
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff? ↗
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular consumer products like Tylenol and Listerine. 
Via Benzinga
News headline image
Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
From Kenvue
Via Business Wire
News headline image
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
News headline image
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
Healthcare giant and Dividend Aristocrat Johnson & Johnson is on track to hit new highs in 2025 and may sustain its rally well into 2026. 
Via MarketBeat
News headline image
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year ↗
Target, PepsiCo, and Kenvue have high yields and inexpensive valuations. 
Via The Motley Fool
News headline image
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice ↗
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on... 
Via Benzinga
News headline image
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff ↗
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks... 
Via Benzinga
News headline image
Kenvue Drives Climate Action Strategy Forward
From Kenvue
Via Business Wire
News headline image
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart ↗
Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win. 
Via Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income. ↗
Via The Motley Fool
News headline image
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers ↗
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets. 
Via Benzinga
Topics Stocks
News headline image
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps ↗
Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster than regular tablets. A federal judge ruled the claims were preempted by FDA... 
Via Benzinga
Topics Lawsuit
News headline image
Donald Trump Owns These 21 Dividend Kings. Should You? ↗
Some of Trump's Dividend Kings deserve a crown more than others. 
Via The Motley Fool
Topics Government
News headline image
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
From Kenvue
Via Business Wire
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.